reglab/housing_qa huggingface dataset:
CO Code § 25-42-101 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 42 - Taxing Authority of Unit of Government Hospital Care Providers|§ 25-42-101. Legislative Declaration

  The general assembly hereby finds and declares that:   State and local governmental hospital care providers form a critical part of the health-care delivery system in Colorado; and    Federal programs require the state to further define a unit of government for certain state and local governmental hospital care providers.        History. Source: L. 2008: Entire article added, p. 1181, § 1, effective May 22.
CO Code § 25-42-102 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 42 - Taxing Authority of Unit of Government Hospital Care Providers|§ 25-42-102. Definitions

 As used in this article, unless the context otherwise requires:    “Eligible elector” means an eligible elector as defined in section 32-1-103 (5)(a)(I), C.R.S., of the taxing area of a unit of government hospital provider.    “Qualified purchaser” means a person domiciled in Colorado who has been issued a direct payment permit number pursuant to section 39-26-103.5, C.R.S.    “Taxing area” means:   In the case of the Denver health and hospital authority, the city and county of Denver;    In the case of a county hospital, the county in which the hospital is located;    In the case of a hospital within a health service district, the health service district;    In the case of the university of Colorado hospital authority, the counties of Adams, Arapahoe, Boulder, Douglas, and Jefferson and the city and county of Broomfield; and    In the case of a municipal hospital, the county in which the hospital is located.       “Unit of government hospital care provider” means:   The Denver health and hospital authority created pursuant to section 25-29-103;    The board of any county hospital created pursuant to section 25-3-301;    A health service district within the meaning of section 32-1-103 (9), C.R.S.;    The university of Colorado hospital authority created pursuant to part 5 of article 21 of title 23, C.R.S.; or    A municipally owned hospital created pursuant to section 31-15-711 (1)(e), C.R.S.        History. Source: L. 2008: Entire article added, p. 1181, § 1, effective May 22.
CO Code § 25-42-104 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 42 - Taxing Authority of Unit of Government Hospital Care Providers|§ 25-42-104. Use of Revenues Derived From Sales Tax

 The revenues derived by a unit of government hospital care provider from the levy and collection of the sales tax authorized by this article shall be in addition to and shall not be used to replace any state funding that the unit of government hospital care provider or any other state or local government entity would otherwise be entitled to receive from the state. The unit of government hospital care provider may use said revenues for any purpose permitted by law or by the terms of its organizational documents.   History. Source: L. 2008: Entire article added, p. 1184, § 1, effective May 22.
CO Code § 25-42-105 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 42 - Taxing Authority of Unit of Government Hospital Care Providers|§ 25-42-105. Preservation of Enterprise Status of Certain Providers and Activities

 The authority granted in this article shall be subject to affirmative action of the governing body of a unit of government hospital care provider to avail itself of this authority and shall be contingent upon electoral approval at an election held pursuant to sections 25-42-103 (1)(a) and 25-42-106 . The enactment of this article shall not affect the treatment of any existing or future activity of a unit of government hospital care provider as an enterprise for purposes of section 20 of article X of the state constitution.   History. Source: L. 2008: Entire article added, p. 1184, § 1, effective May 22.
CO Code § 25-42-106 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 42 - Taxing Authority of Unit of Government Hospital Care Providers|§ 25-42-106. Call, Notice, Conduct, and Determination of Results of Tax Elections

 An election held pursuant to this article may be conducted under the provisions of either the “Uniform Election Code of 1992”, articles 1 to 13 of title 1, C.R.S., or the “Colorado Municipal Election Code of 1965”, article 10 of title 31, C.R.S.   History. Source: L. 2008: Entire article added, p. 1184, § 1, effective May 22.
CO Code § 25-42-107 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 42 - Taxing Authority of Unit of Government Hospital Care Providers|§ 25-42-107. Authority Granted Supplemental to Other Authority

 The authority granted by this article shall be in addition and supplemental to, and not in lieu of, the authority granted by other laws.   History. Source: L. 2008: Entire article added, p. 1184, § 1, effective May 22.
CO Code § 25-43-101 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 43 - Required Head Trauma Guidelines|§ 25-43-101. Short Title

 This article shall be known and may be cited as the “Jake Snakenberg Youth Concussion Act”.   History. Source: L. 2011: Entire article added, (SB 11-040), ch. 67, p. 176, § 1, effective January 1, 2012.
CO Code § 25-43-102 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 43 - Required Head Trauma Guidelines|§ 25-43-102. Definitions

 As used in this article 43, unless the context otherwise requires:    “Health-care provider” means a:   Doctor of medicine;    Doctor of osteopathic medicine;    Licensed nurse practitioner;    Licensed physician assistant;    Licensed physical therapist with training in pediatric neurology or concussion evaluation and management; or    Licensed doctor of psychology with training in neuropsychology or concussion evaluation and management.       “Public recreation facility” means a recreation facility owned or leased by the state of Colorado or a political subdivision thereof.    “Youth athletic activity” means an organized athletic activity where the majority of the participants are eleven years of age or older and under nineteen years of age, and are engaging in an organized athletic game or competition against another team, club, or entity or in practice or preparation for an organized game or competition against another team, club, or entity. A “youth athletic activity” does not include college or university activities. “Youth athletic activity” does not include an activity that is entered into for instructional purposes only, an athletic activity that is incidental to a nonathletic program, or a lesson.     History. Source: L. 2011: Entire article added, (SB 11-040), ch. 67, p. 176, § 1, effective January 1, 2012. L. 2019: IP and (1) amended, (HB 19-1208), ch. 146, p. 1762, § 1, effective August 2.
CO Code § 25-44-104 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 44 - Comprehensive Human Sexuality Education Grant Program|§ 25-44-104. Appropriation - Gifts, Grants, and Donations - Uses

  Beginning in the 2019-20 budget year and each budget year thereafter, the general assembly shall annually appropriate at least one million dollars to the department for the comprehensive human sexuality education grant program.    The department may seek, accept, and expend public or private gifts, grants, and donations from public and private sources to implement this article 44; except that the department shall not accept a gift, grant, or donation that is subject to conditions that are inconsistent with the provisions of section 25-44-102 (2) or any other state law. The department is authorized to expend a reasonable amount of the money appropriated or received for the program for the direct and indirect costs associated with administering the program, unless otherwise provided by any provision related to the department's receipt of federal money that is applied to the program.     History. Source: L. 2013: Entire article added,(HB 13-1081), ch. 303, p. 1611, § 3, effective May 28. L. 2014: (3)(c) repealed,(HB 14-1363), ch. 302, p. 1269, § 28, effective May 31. L. 2019: Entire section R&RE,(HB 19-1032), ch. 408, p. 3603, § 6, effective May 31.    Cross references:   For the legislative declaration in HB 19-1032, see section 1 of chapter 408, Session Laws of Colorado 2019.
CO Code § 25-45-101 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 45 - Access to Treatments for Terminally Ill Patients|§ 25-45-101. Short Title

 This article shall be known and may be cited as the “Right to Try Act”.   History. Source: L. 2014: Entire article added, (HB 14-1281), ch. 220, p. 823, § 1, effective May 17.
CO Code § 25-45-102 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 45 - Access to Treatments for Terminally Ill Patients|§ 25-45-102. Legislative Declaration

  The general assembly finds and declares that:   The process of approval for investigational drugs, biological products, and devices in the United States protects future patients from premature, ineffective, and unsafe medications and treatments over the long run, but the process often takes many years;    Patients who have a terminal illness do not have the luxury of waiting until an investigational drug, biological product, or device receives final approval from the United States food and drug administration;    Patients who have a terminal illness have a fundamental right to attempt to pursue the preservation of their own lives by accessing available investigational drugs, biological products, and devices;    The use of available investigational drugs, biological products, and devices is a decision that should be made by the patient with a terminal illness in consultation with the patient's health-care provider and the patient's health-care team, if applicable; and    The decision to use an investigational drug, biological product, or device should be made with full awareness of the potential risks, benefits, and consequences to the patient and the patient's family.       It is the intent of the general assembly to allow for terminally ill patients to use potentially life-saving investigational drugs, biological products, and devices.     History. Source: L. 2014: Entire article added, (HB 14-1281), ch. 220, p. 823, 1, effective May 17.
CO Code § 25-45-104 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 45 - Access to Treatments for Terminally Ill Patients|§ 25-45-104. Drug Manufacturers - Availability of Investigational Drugs, Biological Products, or Devices - Costs - Insurance Coverage

  A manufacturer of an investigational drug, biological product, or device may make available the manufacturer's investigational drug, biological product, or device to eligible patients pursuant to this article. This article does not require that a manufacturer make available an investigational drug, biological product, or device to an eligible patient.    A manufacturer may:   Provide an investigational drug, biological product, or device to an eligible patient without receiving compensation; or    Require an eligible patient to pay the costs of, or the costs associated with, the manufacture of the investigational drug, biological product, or device.         Nothing in this article expands the coverage provided in sections 10-16-104 (20) or 10-16-104.6, C.R.S.    A health insurance carrier may, but is not required to, provide coverage for the cost of an investigational drug, biological product, or device.    An insurer may deny coverage to an eligible patient from the time the eligible patient begins use of the investigational drug, biological product, or device through a period not to exceed six months from the time the investigational drug, biological product, or device is no longer used by the eligible patient; except that coverage may not be denied for a preexisting condition and for coverage for benefits which commenced prior to the time the eligible patient begins use of such drug, biological product, or device.       If a patient dies while being treated by an investigational drug, biological product, or device, the patient's heirs are not liable for any outstanding debt related to the treatment or lack of insurance due to the treatment.      History. Source: L. 2014: Entire article added, (HB 14-1281), ch. 220, p. 825, 1, effective May 17.
CO Code § 25-45-105 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 45 - Access to Treatments for Terminally Ill Patients|§ 25-45-105. Action Against Health-Care Provider's License or Medicare Certification Prohibited

 Notwithstanding any other law, a licensing board may not revoke, fail to renew, suspend, or take any action against a health-care provider's license issued pursuant to title 12, C.R.S., based solely on the health-care provider's recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product, or device, as long as the recommendations are consistent with medical standards of care. Action against a health-care provider's medicare certification based solely on the health-care provider's recommendation that a patient have access to an investigational drug, biological product, or device is prohibited.   History. Source: L. 2014: Entire article added, (HB 14-1281), ch. 220, p. 826, 1, effective May 17.
CO Code § 25-45-106 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 45 - Access to Treatments for Terminally Ill Patients|§ 25-45-106. Access to Investigational Drugs, Biological Products, and Devices

 An official, employee, or agent of this state shall not block or attempt to block an eligible patient's access to an investigational drug, biological product, or device. Counseling, advice, or a recommendation consistent with medical standards of care from a licensed health-care provider is not a violation of this section.   History. Source: L. 2014: Entire article added, (HB 14-1281), ch. 220, p. 826, 1, effective May 17.
CO Code § 25-45-107 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 45 - Access to Treatments for Terminally Ill Patients|§ 25-45-107. No Cause of Action Created

 This article does not create a private cause of action against a manufacturer of an investigational drug, biological product, or device or against any other person or entity involved in the care of an eligible patient using the investigational drug, biological product, or device, for any harm done to the eligible patient resulting from the investigational drug, biological product, or device, so long as the manufacturer or other person or entity is complying in good faith with the terms of this article, unless there was a failure to exercise reasonable care.   History. Source: L. 2014: Entire article added, (HB 14-1281), ch. 220, p. 827, 1, effective May 17.
CO Code § 25-45-108 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 45 - Access to Treatments for Terminally Ill Patients|§ 25-45-108. Effect on Health-Care Coverage

 Nothing in this section affects the mandatory health-care coverage for participation in clinical trials pursuant to section 10-16-106 (20) , C.R.S.   History. Source: L. 2014: Entire article added, (HB 14-1281), ch. 220, p. 827, 1, effective May 17.
CO Code § 25-47-101 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 47 - Use of Epinephrine Auto-Injectors by Authorized Entities|§ 25-47-101. Definitions

 As used in this article 47:    “Administer” means to directly apply an epinephrine auto-injector to the body of an individual.    “Authorized entity” means an entity or organization, other than a school described in section 22-1-119.5, C.R.S., or a hospital licensed or certified pursuant to section 25-1.5-103 (1)(a)(I)(A) or (1)(a)(II), at which allergens capable of causing anaphylaxis may be present. The term includes but is not limited to recreation camps, colleges and universities, day care facilities, youth sports leagues, amusement parks, restaurants, places of employment, ski areas, and sports arenas.    “Emergency public access station” or “EPAS” means a locked, secure container used to store epinephrine auto-injectors for use under the general oversight of a medical professional, which allows a lay rescuer to consult with a medical professional in real time by audio, televideo, or other similar means of electronic communication. Upon authorization of the consulting medical professional, an EPAS may be unlocked to make an epinephrine auto-injector available.    “Epinephrine auto-injector” means a single-use device used for the automatic injection of a premeasured dose of epinephrine into the human body.    “Health-care practitioner” means a person authorized by law to prescribe any drug or device, acting within the scope of his or her authority.    “Medical professional” means a physician or other person authorized by applicable law to prescribe drugs in this state or another state.    “Pharmacist” has the meaning set forth in section 12-280-103 (35).    “Provide” means to supply one or more epinephrine auto-injectors to an individual.     History. Source: L. 2015: Entire article added, (HB 15-1232), ch. 191, p. 628, § 1, effective May 14. L. 2019: IP and (7) amended, (HB 19-1172), ch. 136, p. 1706, § 173, effective October 1.
CO Code § 25-47-102 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 47 - Use of Epinephrine Auto-Injectors by Authorized Entities|§ 25-47-102. Stock Supply of Epinephrine Auto-Injectors - Emergency Administration

  Notwithstanding any provision of law to the contrary:   Prescribing to an authorized entity permitted. A health-care practitioner may direct the distribution of epinephrine auto-injectors from an in-state prescription drug outlet to an authorized entity for use in accordance with this article, and health-care practitioners may distribute epinephrine auto-injectors to an authorized entity; and    Authorized entities permitted to maintain supply. An authorized entity may acquire and stock a supply of epinephrine auto-injectors pursuant to a prescription issued in accordance with this section.       Epinephrine auto-injectors must be stored:   In a location that will be readily accessible in an emergency;    According to the applicable instructions for use; and    In compliance with any additional requirements that may be established by the department of public health and environment.       An authorized entity shall designate employees or agents who have completed the training required by section 25-47-104 to be responsible for the storage, maintenance, control, and general oversight of epinephrine auto-injectors acquired by the authorized entity.     History. Source: L. 2015: Entire article added, (HB 15-1232), ch. 191, p. 629, § 1, effective May 14.
CO Code § 25-47-103 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 47 - Use of Epinephrine Auto-Injectors by Authorized Entities|§ 25-47-103. Use of Epinephrine Auto-Injectors

  An employee or agent of an authorized entity or other individual who has completed the training required by section 25-47-104 may use epinephrine auto-injectors prescribed pursuant to section 25-47-102 to provide or administer an epinephrine auto-injector to any individual whom the employee, agent, or other individual believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for an epinephrine auto-injector or has previously been diagnosed with an allergy, or to provide an epinephrine auto-injector to a family member, friend, colleague, caregiver, or person with a similar relationship with the individual.    The administration of an epinephrine auto-injector in accordance with this section is neither the practice of medicine nor of any other profession that requires licensure.     History. Source: L. 2015: Entire article added, (HB 15-1232), ch. 191, p. 629, § 1, effective May 14.
CO Code § 25-47-104 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 47 - Use of Epinephrine Auto-Injectors by Authorized Entities|§ 25-47-104. Training

  An employee, agent, or other individual must complete an anaphylaxis training program before using an epinephrine auto-injector. The training must be conducted by a nationally recognized organization experienced in training laypersons in emergency health treatment or by an individual or entity approved by the department of public health and environment. The department of public health and environment may approve specific entities or individuals to conduct training or may approve specific classes by individuals or entities. The training may be conducted online or in-person and, at a minimum, must cover:   How to recognize the signs and symptoms of severe allergic reactions, including anaphylaxis;    The standards and procedures for the storage and administration of an epinephrine auto-injector; and    Emergency follow-up procedures.       The individual or entity that conducts the anaphylaxis training program shall issue a certificate, on a form developed or approved by the department of public health and environment, to each person who successfully completes the anaphylaxis training program.     History. Source: L. 2015: Entire article added, (HB 15-1232), ch. 191, p. 630, § 1, effective May 14.
CO Code § 25-47-105 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 47 - Use of Epinephrine Auto-Injectors by Authorized Entities|§ 25-47-105. Reporting

 An authorized entity that possesses and makes available epinephrine auto-injectors shall submit to the department of public health and environment, on a form developed by the department of public health and environment, a report of each incident on the authorized entity's premises that involves the administration of an epinephrine auto-injector pursuant to section 25-47-103 . The department of public health and environment shall annually publish a report that summarizes and analyzes all reports submitted to it under this section.   History. Source: L. 2015: Entire article added, (HB 15-1232), ch. 191, p. 630, § 1, effective May 14.
CO Code § 25-47-106 (2021)
2021 Colorado Code|Title 25 - Public Health and Environment|Article 47 - Use of Epinephrine Auto-Injectors by Authorized Entities|§ 25-47-106. Emergency Public Access Stations - Life-Saving Allergy Medication

  Notwithstanding any law to the contrary:   A medical professional may prescribe a stock supply of epinephrine auto-injectors to any authorized entity for storage in an EPAS and may place a stock supply of epinephrine auto-injectors in an EPAS maintained by an authorized entity;    A medical professional may consult the user of an EPAS and make the epinephrine auto-injectors stored in the EPAS available to the user; and    Any person may use an EPAS to administer or provide an epinephrine auto-injector to an individual believed in good faith to be experiencing anaphylaxis or to provide an epinephrine auto-injector to a family member, friend, colleague, caregiver, or person with a similar relationship with the individual.       The use of an EPAS in accordance with this article is neither the practice of medicine nor of any other profession that requires licensure.     History. Source: L. 2015: Entire article added, (HB 15-1232), ch. 191, p. 630, § 1, effective May 14.